Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 11 results for "cadila healthcare click"

Cadila Healthcare to buy 8 brands from AstraZeneca India: Sources

According to people close to the matter, Cadila Healthcare has reached a deal to purchase eight brands from AstraZeneca's Indian subsidiary, reported Friday. The acquisition covers the brands Bricarex, Bricarex-A, Bricanyl, ... FirstWord Pharma, 3 hours ago
Zydus acquires six brands from MSD FirstWord Pharma, 3 weeks ago

Zydus Cadila acquires Sentynl Therapeutics, a US based specialty pharmaceutical company

Marks its entry into the specialty prescription market in the US Ahmedabad, India, January 19, 2017 Zydus Cadila, a leading global healthcare provider announced that it has acquired Sentynl Therapeutics Inc., a US based specialty pharma ...
 FirstWord Pharma1 day ago

Zydus receives final approval from the USFDA for Methotrexate Tablets USP

Zydus Cadila has received the final approval from the USFDA to market Methotrexate Tablets USP, 2.5 mg, a chemotherapy drug used for leukemias, lymphomas, breast cancer, lung cancer, head and neck cancers and other cancers. The drug will be ...
 FirstWord Pharma2 days ago

Allergan settles with Zydus and Cadila over Delzicol: 4 things to know

d-based Allergan Pharmaceuticals settled litigation over its Delzicol prescription used to treat ulcerative colitis. Here's what you should know. 1. Allegan settled with Pennington, N.J.-based Zydus Pharmaceuticals and Ahmedabad, India-based ...
 Beckers ASC Review1 month ago

Global Markets Continues to be Volatile

Posted by Equitymaster Global markets ended the week on a dull note with most of the markets ending flat or in the negative territory. Brazil's and China's indices were the only ones which ended the week on a positive note, with gains of 0.5% and 0.3% ...
 Equitymaster.com6 hours ago

Peptic Ulcer Drugs Market Is Expected to Be Valued at US $40,004.3 Mn by 2022

MRRSE has recently added a research document to their roster titled Global Market Study on Peptic Ulcer Drugs: North America to Lead in Global Market During Forecast Period 2016 - 2022, Driven by Increasing NSAID Consumption. This press release ...
 Digital Journal2 weeks ago

Sun Pharma shares trail Sensex first time in seven years

Sun Pharma shares plunged 24% in 2016, its worst performance ever since the company was listed in 1994, Bloomberg data shows Mumbai: The dream run of Sun Pharmaceutical Industries Ltd, India's largest pharmaceutical firm by revenue and market ...
 Livemint.com4 weeks ago

ASCI ticks off 151 ads over misleading claims

In September 2016, ASCI's Consumer Complaints Council (CCC) upheld complaints against 151 out of 199 advertisements BestMediaInfo Bureau | Delhi | December 20, 2016 Out of 151 advertisements against which complaints were upheld, 39 belonged to ...
 Best Media Info1 month ago

Teva to market cannabis inhaler; FDA makes quality metrics voluntary

View: 395 This week, Phispers brings you news on J&J's plans to acquire Actelion and Teva's new medical cannabis inhaler due for launch in Israel. There are pharma deals from across the globe, such as Roche's decision to sell its South Carolina ...
 PharmaCompass1 month ago

Worldstar Awards 2016

World Packaging Organisation WorldStar Awards 2016 The World Packaging Organisation is a nonprofit, nongovernmental, international federation of national packaging institutes and associations, regional packaging ...
 Package Design Magazine1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less